In the last trading session, 1.09 million GeneDx Holdings Corp (NASDAQ:WGS) shares changed hands as the company’s beta touched 2.03. With the company’s per share price at $95.00 changed hands at -$0.83 or -0.87% during last session, the market valuation stood at $2.67B. WGS’s last price was a discount, traded about -21.68% off its 52-week high of $115.60. The share price had its 52-week low at $6.79, which suggests the last value was 92.85% up since then.
Analysts gave the GeneDx Holdings Corp (WGS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WGS as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. GeneDx Holdings Corp’s EPS for the current quarter is expected to be 0.11.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Instantly WGS was in red as seen at the end of in last trading. With action 24.43%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 23.60%, with the 5-day performance at 24.43% in the green. However, in the 30-day time frame, GeneDx Holdings Corp (NASDAQ:WGS) is 22.33% up.
The consensus price target for the stock as assigned by Wall Street analysts is 52, meaning bulls need a downside of -82.69% from its current market value. According to analyst projections, WGS’s forecast low is 34 with 70 as the target high. To hit the forecast high, the stock’s price needs a 26.32% surge from its current level, while the stock would need to tank 64.21% for it to hit the projected low.
GeneDx Holdings Corp (WGS) estimates and forecasts
Year-over-year growth is forecast to reach 17.40% up from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of 79.9M. 6 analysts are of the opinion that GeneDx Holdings Corp’s revenue for the current quarter will be 85.32M. The company’s revenue for the corresponding quarters a year ago was 62.42M and 70.51M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 27.99%. The estimates for the next quarter sales put growth at 20.99%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 96.65%. The 2025 estimates are for GeneDx Holdings Corp earnings to increase by 248.68%, but the outlook for the next 5-year period is at 119.03% per year.
WGS Dividends
GeneDx Holdings Corp is expected to release its next quarterly earnings report in March.
CORVEX MANAGEMENT LP holds the second largest percentage of outstanding shares, with 9.2937% or 2.47 million shares worth $64.66 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund . With 461.76 shares estimated at $43.87 million under it, the former controlled 1.65% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 1.46% of the shares, roughly 410.78 shares worth around $39.02 million.
